{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:26:10Z","timestamp":1775280370409,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.clinthera.2012.01.023","type":"journal-article","created":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T11:04:09Z","timestamp":1330427049000},"page":"668-676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Influence of Sparse Data Sampling on Population Pharmacokinetics: A Post Hoc Analysis of a Pharmacokinetic Study of Morphine in Healthy Volunteers"],"prefix":"10.1016","volume":"34","author":[{"given":"Robert E.","family":"Ariano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Duke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Sitar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2012.01.023_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s002280050199","article-title":"How many patients and blood levels are necessary for population pharmacokinetic analysis?","volume":"51","author":"Br\u00e9ant","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2012.01.023_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2125.2002.01589.x","article-title":"Caffeine in apnoeic Asian neonates: a sparse data analysis","volume":"54","author":"Lee","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2012.01.023_bib3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/0091270005277937","article-title":"An evaluation of an optimal sampling strategy for meropenem in febrile neutropenics","volume":"45","author":"Ariano","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2012.01.023_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03010823","article-title":"Kinetic disposition of morphine in young males after intravenous loading and maintenance infusions","volume":"33","author":"Sitar","year":"1986","journal-title":"Can Anaesth Soc J"},{"key":"10.1016\/j.clinthera.2012.01.023_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/clpt.1983.180","article-title":"Age-related morphine kinetics","volume":"34","author":"Owen","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2012.01.023_bib6","series-title":"User Manual for Version 11.0 USC*PACK Collection of PC Programs","author":"Jelliffe","year":"2002"},{"key":"10.1016\/j.clinthera.2012.01.023_bib7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Automat Contr"},{"key":"10.1016\/j.clinthera.2012.01.023_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","article-title":"Some suggestions for measuring predictive performance","volume":"9","author":"Sheiner","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.clinthera.2012.01.023_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/03602537508993748","article-title":"The metabolism of morphine and heroin in man","volume":"4","author":"Boerner","year":"1975","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.clinthera.2012.01.023_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0009-9236(96)90058-2","article-title":"Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers","volume":"60","author":"Lotsch","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2012.01.023_bib11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2165\/00003088-199732040-00003","article-title":"Role of population pharmacokinetics in drug development","volume":"32","author":"Samara","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2012.01.023_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10928-006-9040-2","article-title":"Population pharmacokinetics of risperidone and 9-hydroyrisperidone in patients with acute episodes associated with bipolar I disorder","volume":"34","author":"Vermeulen","year":"2007","journal-title":"Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.clinthera.2012.01.023_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00007691-200206000-00006","article-title":"NONMEM and NPEM2 population modeling: a comparison using tobramycin data in neonates","volume":"24;","author":"de Hoog","year":"2002","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2012.01.023_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00003088-200645040-00003","article-title":"Parametric and nonparametric population methods","volume":"45","author":"Bustad","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2012.01.023_bib15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/BF01070904","article-title":"Optimal sampling times for pharmacokinetic experiments","volume":"9","author":"D'Argenio","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.clinthera.2012.01.023_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1114\/1.1533074","article-title":"An evaluation of population D-optimal designs via pharmacokinetic simulations","volume":"31","author":"Hooker","year":"2003","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.clinthera.2012.01.023_bib17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00007691-200012000-00006","article-title":"Population pharmacokinetics of flucytosine: comparison and validation of three models using STS, NPEM, and NONMEM","volume":"22","author":"Vermes","year":"2000","journal-title":"Ther Drug Monit"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812000690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812000690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:48:41Z","timestamp":1758962921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291812000690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0149291812000690"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2012.01.023","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Influence of Sparse Data Sampling on Population Pharmacokinetics: A Post Hoc Analysis of a Pharmacokinetic Study of Morphine in Healthy Volunteers","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2012.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier HS Journals, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}